Anthropic CEO Dario Amodei predicts AI could help cure or prevent most diseases within five to 10 years, while biological data and clinical validation remain key hurdles.
Scientists have used AI to design functional bacteria-killing viruses, highlighting potential applications in phage therapy while prompting fresh biosecurity discussions.
Bristol Myers Squibb is deploying NVIDIA's latest AI computing platform to accelerate drug discovery, clinical research and AI-driven pharmaceutical innovation.
Reliance backed Strand Life Sciences has secured an Indian patent for an AI based technology that improves blood cancer detection through genomic data analysis.
Anthropic has launched Claude Science, an AI workbench designed to help researchers accelerate scientific discovery through integrated AI tools and workflows.
Cambridge researchers have developed an AI-designed coronavirus vaccine candidate aimed at providing protection against multiple coronavirus strains.
Regeneron Pharmaceuticals has established a global capability centre in Hyderabad to support technology, data, and R&D operations.
OpenAI has launched Rosalind, an AI model designed to support research and discovery in life sciences.
South Korea has introduced a fast track patent programme to accelerate approvals for AI and biotech startups, strengthening its innovation ecosystem.
